173 related articles for article (PubMed ID: 35576884)
1. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
4. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted neutral and cationic iridium(III) anticancer complexes chelating simple hybrid sp
Li P; Guo L; Li J; Yang Z; Fu H; Lai K; Dong H; Fan C; Liu Z
Dalton Trans; 2024 Jan; 53(5):1977-1988. PubMed ID: 38205595
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
8. Cyclometalated Iridium(III) Complexes as Mitochondria-targeting Photosensitizers against Cisplatin-resistant Cells.
Xiong K; Zhou Y; Lin X; Kou J; Lin M; Guan R; Chen Y; Ji L; Chao H
Photochem Photobiol; 2022 Jan; 98(1):85-91. PubMed ID: 33617666
[TBL] [Abstract][Full Text] [Related]
9. Brominated cyclometalated iridium(III) complexes for mitochondrial immobilization as potential anticancer agents.
Liu B; Chen Z; Li Y; Du XF; Zhang W; Zhang W; Lai Y; Li Y
Dalton Trans; 2022 May; 51(19):7650-7657. PubMed ID: 35510904
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, anticancer efficacy evaluation of ruthenium(II) and iridium(III) polypyridyl complexes toward A549 cells.
Liang L; Yang Y; Liu H; Yuan F; Yuan Y; Li W; Huang C; Chen J; Liu Y
J Biol Inorg Chem; 2023 Jun; 28(4):421-437. PubMed ID: 37097484
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial targeting half-sandwich iridium(III) and ruthenium(II) dppf complexes and in vitro anticancer assay.
Liu J; Wu Y; Yang G; Liu Z; Liu X
J Inorg Biochem; 2023 Feb; 239():112069. PubMed ID: 36423395
[TBL] [Abstract][Full Text] [Related]
13. Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments.
He SF; Han WC; Shao YY; Zhang HB; Hong WX; Yang QH; Zhang YQ; He RR; Sun J
Bioorg Chem; 2023 Dec; 141():106867. PubMed ID: 37734195
[TBL] [Abstract][Full Text] [Related]
14. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in SGC-7901 cells by iridium(III) complexes via endoplasmic reticulum stress-mitochondrial dysfunction pathway.
Wang J; Liu H; Wu X; Shi C; Li W; Yuan Y; Liu Y; Xing D
J Biol Inorg Chem; 2022 Aug; 27(4-5):455-469. PubMed ID: 35817878
[TBL] [Abstract][Full Text] [Related]
16. Lysosome-targeted cyclometalated iridium(III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy.
Lu JJ; Ma XR; Xie K; Chen MR; Huang B; Li RT; Ye RR
Metallomics; 2022 Sep; 14(9):. PubMed ID: 36073756
[TBL] [Abstract][Full Text] [Related]
17. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
18. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
19. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
20. Iridium(III) complexes entrapped in liposomes trigger mitochondria-mediated apoptosis and GSDME-mediated pyroptosis.
Zhang H; Liao X; Wu X; Shi C; Zhang Y; Yuan Y; Li W; Wang J; Liu Y
J Inorg Biochem; 2022 Mar; 228():111706. PubMed ID: 35033830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
